These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8373935)
1. Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population. Walton RG; Hudak R; Green-Waite RJ Biol Psychiatry; 1993 Jul 1-15; 34(1-2):13-7. PubMed ID: 8373935 [TBL] [Abstract][Full Text] [Related]
2. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. Geha R; Buckley CE; Greenberger P; Patterson R; Polmar S; Saxon A; Rohr A; Yang W; Drouin M J Allergy Clin Immunol; 1993 Oct; 92(4):513-20. PubMed ID: 8409113 [TBL] [Abstract][Full Text] [Related]
3. Aspartame ingestion and headaches: a randomized crossover trial. Van den Eeden SK; Koepsell TD; Longstreth WT; van Belle G; Daling JR; McKnight B Neurology; 1994 Oct; 44(10):1787-93. PubMed ID: 7936222 [TBL] [Abstract][Full Text] [Related]
4. "Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population" by Walton et al. Butchko HH Biol Psychiatry; 1994 Aug; 36(3):206-8. PubMed ID: 7948460 [No Abstract] [Full Text] [Related]
9. Aspartame use by persons with diabetes. Nehrling JK; Kobe P; McLane MP; Olson RE; Kamath S; Horwitz DL Diabetes Care; 1985; 8(5):415-7. PubMed ID: 3902420 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Soares CN; Almeida OP; Joffe H; Cohen LS Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Marangell LB; Martinez JM; Zboyan HA; Kertz B; Kim HF; Puryear LJ Am J Psychiatry; 2003 May; 160(5):996-8. PubMed ID: 12727707 [TBL] [Abstract][Full Text] [Related]
15. Administration of aspartame in non-insulin-dependent diabetics. Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296 [TBL] [Abstract][Full Text] [Related]
16. Methylphenidate in mild depression: a double-blind controlled trial. Mattes JA J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773 [TBL] [Abstract][Full Text] [Related]
17. Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects. Spiers PA; Sabounjian L; Reiner A; Myers DK; Wurtman J; Schomer DL Am J Clin Nutr; 1998 Sep; 68(3):531-7. PubMed ID: 9734727 [TBL] [Abstract][Full Text] [Related]
18. A double-blind study of bupropion and placebo in depression. Feighner JP; Meredith CH; Stern WC; Hendrickson G; Miller LL Am J Psychiatry; 1984 Apr; 141(4):525-9. PubMed ID: 6422779 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292 [TBL] [Abstract][Full Text] [Related]
20. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial. Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]